GENE ONLINE|News &
Opinion
Blog

2017-08-07| Interviews

“Project Oxygen”of Precision Medicine Exclusive Interview of Dr. Chris Tsai, Founder of Bionet

by GeneOnline
Share To
The U.S. Food and Drug Administration allowed 23andMe to directly sell genetic testing those provides information on an individual’s genetic predisposition to certain medical disease or conditions in April this year. The approval become a milestone in the field of genetic testing. The development of genetic testing leads to an information explosion. Many people may question: "Is these information just for a one time use? Can the results be reused in the future?" GeneOnline interviewed Dr. Chris Tsai, founder of Bionet, to share how he assembled the core technology of Bionet and GGA. Bionet is a company aiming to provide everyone from youngers to seniors with a better life quality by integrating and reusing medical big data.

It's free! Log in now to read

LATEST
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scientists Identified Potential New Drugs to Combat Blindness
2023-05-21
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
EVENT
2023-05-16
The 2nd International Healthcare Week
Hong Kong , China
2023-06-02
2023 ASCO annual meeting
Chicago, USA
2023-07-26
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023-09-06
2023 Bio Asia Pacific
Bangkok, Thailand
Scroll to Top